According to Tonix Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -$0.12 B. a decrease over its 2022 earnings that were of -$0.12 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | -$0.12 B | 5.61% |
2022 | -$0.12 B | 21.43% |
2021 | -$92.32 M | 82.76% |
2020 | -$50.52 M | 75.22% |
2019 | -$28.83 M | 9.52% |
2018 | -$26.33 M | 23.63% |
2017 | -$21.3 M | -45.36% |
2016 | -$38.97 M | -19.09% |
2015 | -$48.17 M | 74.15% |
2014 | -$27.66 M | 153.99% |
2013 | -$10.89 M | |
2011 | -$5.26 M | 29538.74% |
2010 | -$0.02 M | -42.58% |
2009 | -$0.04 M | 46.05% |
2008 | -$0.03 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Aerie Pharmaceuticals AERI | -$23.25 M | -80.37% | ๐บ๐ธ USA |
Eagle Pharmaceuticals
EGRX | $35.65 M | -130.12% | ๐บ๐ธ USA |